Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Bextra withdrawal dents Pfizer’s sales juggernaut

April 22, 2005 Sales and Marketing

The suspension and withdrawal of Pfizer's Cox-II inhibitor Bextra has forced the company to cut its profit forecast for 2005, …
News

US court rules in favour of Lilly’s Zyprexa

April 18, 2005 Sales and Marketing

Lilly's US patent on blockbuster antipsychotic drug Zyprexa (olanzapine) has been upheld, after a Supreme Court ruled against its generic …
News

Japanese companies merge to form Astellas

April 13, 2005 Sales and Marketing

News

Eloxatin and Campto gain new NICE approval

April 13, 2005 Sales and Marketing

NICE has recommended two more chemotherapy drugs for the first-line treatment of advanced colorectal cancer.The institute said that Sanofi-Aventis' Eloxatin …
News

Secrets of a youthful brand

April 12, 2005 Sales and Marketing Pan Advertising, Teva, lilly

 Today, more than ever before, the pharmaceutical industry is constantly being reminded that a blockbuster drug’s days are numbered and …
Feature

New depression treatment relieves sleep problems in patients

April 12, 2005 Sales and Marketing

An innovative new depression drug has shown improved benefits over existing treatments, according to data presented by its manufacturer Servier.Valdoxan …
News

Serono hit by two late-stage failures

April 8, 2005 Research and Development, Sales and Marketing

Serono has halted development of a late-stage psoriasis drug and stopped another trial for a new skin cancer drug.Both drugs …
News

Bextra suspended from European and US markets

April 8, 2005 Sales and Marketing

News

No salesforce purge in Pfizer’s $4 billion cuts

April 7, 2005 Sales and Marketing

Pfizer has set out a $4 billion cost cutting programme for the next three years in an attempt to return …
News

New hepatitis B treatment approved in US

April 6, 2005 Sales and Marketing

Bristol-Myers Squibb has received US approval for its hepatitis B treatment Baraclude after a six-month priority review.Baraclude (entecavir) is BMS's …
News

Interactive sampling

April 4, 2005 Sales and Marketing

The internet has changed the way many of us live our lives, from grocery shopping to booking holidays, but can …
Feature

Europe unaffected by GSK’s manufacturing problems

March 31, 2005 Sales and Marketing

Batches of GlaxoSmithKline's diabetes treatment Avandamet and depression treatment Paxil CR have been seized in the US due to continuing …
News

New drug applications to keep rising, European regulator says

March 31, 2005 Sales and Marketing

The EMEA says it received 51 new drug applications in 2004, a figure which represents a significant rise over the …
News

Industry heads speak out against new European hurdle

March 31, 2005 Sales and Marketing

Two leading pharmaceutical executives have criticised European regulators for demanding that new treatments be compared with existing drugs before they …
News

Serono hails progress towards MS gene map

March 22, 2005 Sales and Marketing

Serono has announced it has reached a major milestone towards identifying the genes involved in multiple sclerosis.The company has identified …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025